Atherogenics atherogenics.com


Public lists: Pharma Startups (4732)

AtheroGenics is an emerging pharmaceutical company, focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as heart disease (atherosclerosis), asthma and arthritis. Based on a proprietary drug discovery technology platform called vascular protectant technology, the company designed its lead product candidate, AGI-1067, to benefit patients with coronary artery disease, which is atherosclerosis of the blood vessels of the...Show all

AtheroGenics is an emerging pharmaceutical company, focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as heart disease (atherosclerosis), asthma and arthritis. Based on...Show all

Company (Alive / Active)

Phone: 678-336-2500

Fax:

8995 Westside Parkway

Alpharetta, 30009
Georgia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Atherogenics $58.4M Jun 25, 2001
GlycoMimetics $119M Jan 10, 2014
ActivBiotics $36.7M Jan 1, 2008
See all 70 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Atherogenics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 20 investors

Competitors

Company Status Description Investors
See all 70 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)